Elimination of fluconazole during continuous renal replacement therapy. An in vitro assessment
Frédéric J. Baud, Vincent Jullien, Tarik Abarou, B. Pilmis, Jean‐Herlé Raphalen, Pascal Houzé, Pierre Carli, Lionel Lamhaut
Abstract
Introduction: Continuous renal replacement therapy (CRRT) efficiently eliminates fluconazole. However, the routes of elimination were not clarified. Adsorption of fluconazole by filters is a pending question. We studied the elimination of fluconazole in a model mimicking a session of CRRT in humans using the NeckEpur ® model. Two filters were studied. Methods: The AV1000 ® -polysulfone filter with the Multifiltrate Pro. Fresenius and the ST150 ® -polyacrylonitrile filter with the Prismaflex. Baxter-Gambro were studied. Continuous filtration used a flowrate of 2.5 L/h in post-dilution only. Session were made in duplicate. Routes of elimination were assessed using the NeckEpur ® model. Results: The mean measured initial fluconazole concentration (mean ± SD) for the four sessions in the central compartment (CC) was 14.9 ± 0.2 mg/L. The amount eliminated from the CC at the end of 6 h-session at a 2.5 L/h filtration flowrate for the AV1000 ® -polysulfone and the ST150 ® -polyacrylonitrile filters were 90%–93% and 96%–94%, respectively; the clearances from the central compartment (CC) were 2.5–2.6 and 2.4–2.3 L/h, respectively. The means of the instantaneous sieving coefficient were 0.94%–0.91% and 0.99%–0.91%, respectively. The percentages of the amount eliminated from the CC by filtration/adsorption were 100/0%–95/5% and 100/0%–100/0%, respectively. Conclusion: Neither the ST150 ® -polyacrylonitrile nor the AV1000 ® -polysulfone filters result in any significant adsorption of fluconazole.